Collins Karikari

4.5k total citations · 1 hit paper
33 papers, 3.1k citations indexed

About

Collins Karikari is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Collins Karikari has authored 33 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 20 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Collins Karikari's work include Pancreatic and Hepatic Oncology Research (17 papers), Epigenetics and DNA Methylation (9 papers) and Cancer Genomics and Diagnostics (8 papers). Collins Karikari is often cited by papers focused on Pancreatic and Hepatic Oncology Research (17 papers), Epigenetics and DNA Methylation (9 papers) and Cancer Genomics and Diagnostics (8 papers). Collins Karikari collaborates with scholars based in United States, India and Germany. Collins Karikari's co-authors include Anirban Maitra, Georg Feldmann, Héctor M. Álvarez, Michael E. Mullendore, Savita Bisht, Volker Fendrich, William Matsui, Kathleen L. Gabrielson, Djahida Bedja and Dipankar Pramanik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Collins Karikari

33 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers

2007 537 citations Georg Feldmann, Surajit Dhara et al. Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Collins Karikari United States	26	2.0k	1.4k	894	291	271	33	3.1k
Qian Xiao China	27	1.3k 0.6×	952 0.7×	609 0.7×	509 1.7×	184 0.7×	111	2.7k
Maria Hatziapostolou United States	29	2.0k 1.0×	548 0.4×	1.4k 1.6×	461 1.6×	126 0.5×	52	3.2k
Yubin Mao China	18	1.1k 0.6×	687 0.5×	502 0.6×	220 0.8×	106 0.4×	23	2.0k
Hans‐Dieter Royer Germany	29	2.1k 1.0×	932 0.7×	598 0.7×	543 1.9×	442 1.6×	48	3.2k
Rebecca T. Marquez United States	24	1.8k 0.9×	481 0.3×	867 1.0×	290 1.0×	160 0.6×	32	3.1k
Kathryn L. Schwertfeger United States	29	1.8k 0.9×	986 0.7×	891 1.0×	665 2.3×	97 0.4×	53	3.1k
Qiang Fu China	23	1.0k 0.5×	494 0.3×	408 0.5×	439 1.5×	62 0.2×	118	2.2k
Elizabeth C. Arner United States	35	1.2k 0.6×	658 0.5×	1.3k 1.4×	274 0.9×	142 0.5×	64	4.1k
Ester Sànchez‐Tilló Spain	24	1.9k 1.0×	879 0.6×	601 0.7×	468 1.6×	215 0.8×	34	2.9k
Kathleen L. O’Connor United States	28	2.0k 1.0×	709 0.5×	768 0.9×	314 1.1×	140 0.5×	56	3.0k

Countries citing papers authored by Collins Karikari

Since Specialization

Citations

This map shows the geographic impact of Collins Karikari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Collins Karikari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Collins Karikari more than expected).

Fields of papers citing papers by Collins Karikari

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Collins Karikari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Collins Karikari. The network helps show where Collins Karikari may publish in the future.

Co-authorship network of co-authors of Collins Karikari

This figure shows the co-authorship network connecting the top 25 collaborators of Collins Karikari. A scholar is included among the top collaborators of Collins Karikari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Collins Karikari. Collins Karikari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pramanik, Dipankar, Nathaniel R. Campbell, Collins Karikari, et al.. (2011). Restitution of Tumor Suppressor MicroRNAs Using a Systemic Nanovector Inhibits Pancreatic Cancer Growth in Mice. Molecular Cancer Therapeutics. 10(8). 1470–1480. 240 indexed citations

Chenna, Venugopal, Chaoxin Hu, Dipankar Pramanik, et al.. (2011). A Polymeric Nanoparticle Encapsulated Small-Molecule Inhibitor of Hedgehog Signaling (NanoHHI) Bypasses Secondary Mutational Resistance to Smoothened Antagonists. Molecular Cancer Therapeutics. 11(1). 165–173. 69 indexed citations

Garrido‐Laguna, Ignacio, Maria Uson, N.V. Rajeshkumar, et al.. (2011). Tumor Engraftment in Nude Mice and Enrichment in Stroma- Related Gene Pathways Predict Poor Survival and Resistance to Gemcitabine in Patients with Pancreatic Cancer. Clinical Cancer Research. 17(17). 5793–5800. 179 indexed citations

Kwei, Kevin, A. Hunter Shain, Ryan J. Bair, et al.. (2011). SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer. PLoS ONE. 6(8). e23924–e23924. 41 indexed citations

Feldmann, Georg, Anjali Mishra, Savita Bisht, et al.. (2011). Cyclin-dependent kinase inhibitor Dinaciclib (SCH727965) inhibits pancreatic cancer growth and progression in murine xenograft models. Cancer Biology & Therapy. 12(7). 598–609. 102 indexed citations

Fendrich, Volker, Edwin C. Oh, Seungmin Bang, et al.. (2011). Ectopic Overexpression of Sonic Hedgehog (Shh) Induces Stromal Expansion and Metaplasia in the Adult Murine Pancreas. Neoplasia. 13(10). 923–IN18. 32 indexed citations

Feldmann, Georg, Collins Karikari, Marco Dal Molin, et al.. (2011). Inactivation ofBrca2cooperates withTrp53^R172Hto induce invasive pancreatic ductal adenocarcinomas in mice. Cancer Biology & Therapy. 11(11). 959–968. 24 indexed citations

Bisht, Savita, Masamichi Mizuma, Georg Feldmann, et al.. (2010). Systemic Administration of Polymeric Nanoparticle-Encapsulated Curcumin (NanoCurc) Blocks Tumor Growth and Metastases in Preclinical Models of Pancreatic Cancer. Molecular Cancer Therapeutics. 9(8). 2255–2264. 169 indexed citations

Ryu, Ji Kon, Seung‐Mo Hong, Collins Karikari, et al.. (2010). Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma. Pancreatology. 10(1). 66–73. 111 indexed citations

10.

Singh, Mansher, et al.. (2009). Cell cycle inhibition and apoptosis induced by curcumin in Ewing sarcoma cell line SK-NEP-1. Medical Oncology. 27(4). 1096–1101. 20 indexed citations

11.

Shi, Chanjuan, Paul J. Thuluvath, Collins Karikari, et al.. (2009). Ultrasensitive Detection of KRAS2 Mutations in Bile and Serum from Patients with Biliary Tract Carcinoma Using LigAmp Technology. Journal of Molecular Diagnostics. 11(6). 583–589. 8 indexed citations

12.

Karikari, Collins, Georg Feldmann, Savita Bisht, et al.. (2009). The Axl receptor tyrosine kinase confers an adverse prognostic influence in pancreatic cancer and represents a new therapeutic target. Cancer Biology & Therapy. 8(7). 618–626. 159 indexed citations

13.

Lotterman, Craig, Collins Karikari, Noriyuki Omura, et al.. (2009). Epigenetic Silencing of MicroRNA miR-107 Regulates Cyclin-Dependent Kinase 6 Expression in Pancreatic Cancer. Pancreatology. 9(3). 293–301. 182 indexed citations

14.

Kwei, Kevin, Murali Dharan Bashyam, Jessica Kao, et al.. (2008). Genomic Profiling Identifies GATA6 as a Candidate Oncogene Amplified in Pancreatobiliary Cancer. PLoS Genetics. 4(5). e1000081–e1000081. 82 indexed citations

15.

Feldmann, Georg, Nils Habbe, Savita Bisht, et al.. (2008). Hedgehog inhibition prolongs survival in a genetically engineered mouse model of pancreatic cancer. Gut. 57(10). 1420–1430. 146 indexed citations

16.

Feldmann, Georg, Surajit Dhara, Volker Fendrich, et al.. (2007). Blockade of Hedgehog Signaling Inhibits Pancreatic Cancer Invasion and Metastases: A New Paradigm for Combination Therapy in Solid Cancers. Cancer Research. 67(5). 2187–2196. 537 indexed citations breakdown →

17.

Habbe, Nils, et al.. (2006). Mitochondrial DNA Mutations in Pancreatic Cancer. International Journal of Gastrointestinal Cancer. 37(2-3). 57–64. 29 indexed citations

18.

Bashyam, Murali Dharan, Ryan J. Bair, Young H. Kim, et al.. (2005). Array-Based Comparative Genomic Hybridization Identifies Localized DNA Amplifications and Homozygous Deletions in Pancreatic Cancer. Neoplasia. 7(6). 556–IN16. 149 indexed citations

19.

Gbakima, Aiah A, Maxwell A. Appawu, Samuel Dadzie, et al.. (2005). Lymphatic filariasis in Ghana: establishing the potential for an urban cycle of transmission. Tropical Medicine & International Health. 10(4). 387–392. 25 indexed citations

20.

Karikari, Collins, et al.. (2004). Sex-specific development of cortical monoamine levels in mouse. Developmental Brain Research. 151(1-2). 187–191. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact